Skip to content

Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion

Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03357146
Acronym
RAO-OCTA
Enrollment
42
Registered
2017-11-29
Start date
2017-01-09
Completion date
2021-08-30
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Artery Occlusion

Brief summary

Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion with non-invasive, non-contact optical coherence tomography angiography.

Detailed description

Occlusion of the retinal arteries is an emergency which causes sudden, painless unilateral vision loss. Loss of blood flow causes ischemic damage to the retina. The extent of damage depends on the area affected. Following the acute phase of the disease re-canalization occurs and lesser blood flow can be detected usually without functional recovery. Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion. Standard procedures to examine this disease include retinoscopy following pupil dilation, fluorescein angiography and more recently, optical coherence tomography (OCT). The latest direction in OCT development was OCT angiography (OCTA) which is a software upgrade that allows detection of blood flow based on motion contrast. Similar to previous OCT machines OCTA is also non-invasive and non-contact and does not require any intravenous agents. OCT machines are approved in the EU and the US and are not experimental devices. The device used in this study is the commercially available Zeiss Cirrus HD OCT Angioplex 5000 that operates with spectral-domain technology.

Interventions

DEVICEOptical coherence tomography angiography

OCTA scans per built-in device protocol

Sponsors

Semmelweis University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* central or branch retinal artery occlusion * at least 6 months of onset * signed informed consent

Exclusion criteria

* known epilepsy * incapacity * presence of optical media opacities that would disturb the imaging * presence of other retinal diseases that would disturb the evaluation of images

Design outcomes

Primary

MeasureTime frame
Capillary density in relation to healthy subjectsThrough study completion, 1 year

Secondary

MeasureTime frame
Correlation of capillary density and retinal thicknessThrough study completion, 1 year

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026